News
DANNCE.AI Raises $2.6 Million; Launches to Provide Clinicians and Drug Developers an AI Biomarkers Platform to Characterize Drug Effects and Optimize Neurological Care
DANNCE.ai, a start-up from the lab of Assistant Professor Timothy Dunn (BME, Pratt), is also in the Duke Capital Partners portfolio.